Covid-19 virus have killed millions of people in different countries including our country, Kenya. Furthermore, many countries are struggling to vaccinate their citizens to end this terrible pandemic which have caused millions of people to live in fear.
Furthermore, scientists are struggling everyday to invent new medicine that can be used to treat this disease.
According to the source, good news have emerge from UK as the country have revealed that, it will start using Ronapreve medicine to treat more than 50 year-old Covid-19 patients from Next week. This has been revealed by Health Secretary Sajid Javid. Look his statement in this screenshot below.
The importance of this drug is that it reduces chances of staying in hospital for several days and also lowers the risk of deaths for almost 20%.
Furthermore, remember to sanitize and follow all guidelines from the ministry of health.
What are your views?
Comment and share!
Content created and supplied by: Felohnyaz (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More